Paper1361079
Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky EK and 3 others. Semin Oncol, 1992. Cited by 378 papers, by iCite.
Cite this record
ConductScience Library. Taxol: the first of the taxanes, an important new class of antitumor agents. Papers, record 1361079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1361079
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drugs, Investigational | Major topic |
| Neoplasms | Major topic |
| Paclitaxel | Major topic |
| Taxoids | Major topic |
| Animals | |
| Antineoplastic Agents, Phytogenic | |
| Breast Neoplasms | |
| Clinical Trials as Topic | |
| Docetaxel | |
| Drug Evaluation | |
| Drug Evaluation, Preclinical | |
| Female | |
| Forecasting | |
| Humans | |
| Lung Neoplasms | |
| Ovarian Neoplasms |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 378 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40136430 | The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40136430 | PubMed |
| 38984579 | Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities. | Curr Drug Metab | 2024 | https://conductscience.org/library/papers/38984579 | PubMed |
| 38004622 | In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38004622 | PubMed |
| 35070357 | Antiproliferative and cytotoxic activity of Geraniaceae plant extracts against five tumor cell lines. | Future Sci OA | 2022 | https://conductscience.org/library/papers/35070357 | PubMed |
| 34138035 | Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition. | Nanomicro Lett | 2019 | https://conductscience.org/library/papers/34138035 | PubMed |
| 33684837 | Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells? | Transl Oncol | 2021 | https://conductscience.org/library/papers/33684837 | PubMed |
| 33669867 | Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33669867 | PubMed |
| 32576580 | Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model. | Cancer Genomics Proteomics | 2020 | https://conductscience.org/library/papers/32576580 | PubMed |
| 32500953 | High-throughput, microscope-based sorting to dissect cellular heterogeneity. | Mol Syst Biol | 2020 | https://conductscience.org/library/papers/32500953 | PubMed |
| 32104480 | Redox-sensitive micelles for targeted intracellular delivery and combination chemotherapy of paclitaxel and all-trans-retinoid acid. | Asian J Pharm Sci | 2019 | https://conductscience.org/library/papers/32104480 | PubMed |
| 31683688 | Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment. | Molecules | 2019 | https://conductscience.org/library/papers/31683688 | PubMed |
| 31097879 | Three-Dimensional Microphase Separation and Synergistic Permeability in Stacked Lipid-Polymer Hybrid Membranes. | Chem Mater | 2017 | https://conductscience.org/library/papers/31097879 | PubMed |
| 30582043 | Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2. | Heliyon | 2018 | https://conductscience.org/library/papers/30582043 | PubMed |
| 30187352 | Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion. | Drug Deliv Transl Res | 2019 | https://conductscience.org/library/papers/30187352 | PubMed |
| 30011808 | Amorphous Nanosuspensions Aggregated from Paclitaxel⁻Hemoglobulin Complexes with Enhanced Cytotoxicity. | Pharmaceutics | 2018 | https://conductscience.org/library/papers/30011808 | PubMed |
| 29878001 | Nanoscale partitioning of paclitaxel in hybrid lipid-polymer membranes. | Analyst | 2018 | https://conductscience.org/library/papers/29878001 | PubMed |
| 29774078 | Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis. | Theranostics | 2018 | https://conductscience.org/library/papers/29774078 | PubMed |
| 29180863 | Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. | Int J Nanomedicine | 2017 | https://conductscience.org/library/papers/29180863 | PubMed |
| 29130448 | A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. | Biomedicine (Taipei) | 2017 | https://conductscience.org/library/papers/29130448 | PubMed |
| 28978013 | Microtubule inhibitor, SP-6-27 inhibits angiogenesis and induces apoptosis in ovarian cancer cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/28978013 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1361079
GET https://conductscience.org/api/papers/v1/1361079/cited_by?page=2